Prevalence of SCN1A-Related Dravet Syndrome among Children Reported with Seizures following Vaccination: A Population-Based Ten-Year Cohort Study
Open Access
- 6 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6), e65758
- https://doi.org/10.1371/journal.pone.0065758
Abstract
To determine the prevalence of Dravet syndrome, an epileptic encephalopathy caused by SCN1A-mutations, often with seizure onset after vaccination, among infants reported with seizures following vaccination. To determine differences in characteristics of reported seizures after vaccination in children with and without SCN1A-related Dravet syndrome. Data were reviewed of 1,269 children with seizures following immunization in the first two years of life, reported to the safety surveillance system of the Dutch national immunization program between 1 January 1997 and 31 December 2006. Selective, prospective follow-up was performed of children with clinical characteristics compatible with a diagnosis of Dravet syndrome. In 21.9% (n = 279) of children, a diagnosis of Dravet syndrome could not be excluded based on available clinical data (median age at follow-up 16 months). Additional follow-up data were obtained in 83.9% (n = 234) of these children (median age 8.5 years). 15 (1.2% of 1,269; 95%CI:0.6 to 1.8%) children were diagnosed with SCN1A-related Dravet syndrome. Of all reported seizures following vaccinations in the first year of life, 2.5% (95%CI:1.3 to 3.6%) were due to SCN1A-related Dravet syndrome, as were 5.9% of reported seizures (95%CI:3.1 to 8.7%) after 2nd or 3rd DTP-IPV-Hib vaccination. Seizures in children with SCN1A-related Dravet syndrome occurred more often with a body temperature below 38.5°C (57.9% vs. 32.6%, p = 0.020) and reoccurred more often after following vaccinations (26.7% vs. 4.0%, p = 0.003), than in children without a diagnosis of SCN1A-related Dravet Syndrome. Although Dravet syndrome is a rare genetic epilepsy syndrome, 2.5% of reported seizures following vaccinations in the first year of life in our cohort occurred in children with this disorder. Knowledge on the specific characteristics of vaccination-related seizures in this syndrome might promote early diagnosis and indirectly, public faith in vaccination safety.This publication has 33 references indexed in Scilit:
- When Should Clinicians Order Genetic Testing for Dravet Syndrome?Pediatric Neurology, 2011
- Molecular genetics of Dravet syndromeDevelopmental Medicine and Child Neurology, 2011
- The core Dravet syndrome phenotypeEpilepsia, 2011
- Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndromeJournal of Medical Genetics, 2010
- Genetic testing in the epilepsies—Report of the ILAE Genetics CommissionEpilepsia, 2010
- A Screening test for the prediction of Dravet syndrome before one year of ageEpilepsia, 2007
- De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective studyThe Lancet Neurology, 2006
- The MMR vaccination and autism controversy in United Kingdom 1998–2005: Inevitable community outrage or a failure of risk communication?Vaccine, 2006
- Early diagnosis of severe myoclonic epilepsy in infancyBrain & Development, 1992
- Epidemiology of Severe Myoclonic Epilepsy of InfancyEpilepsia, 1990